NCT02752282

Brief Summary

This study is a counseling intervention for new LNG-IUS users. The study explores the use of video technology to deliver anticipatory counseling on LNG-IUS side-effects, adjustment periods and bleeding changes to women newly using the LNG-IUS for contraceptive purposes. The primary aim is to understand if anticipatory counseling delivered via video can increase LNG-IUS satisfaction and continuation of the device in the first 6 months of use.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
178

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 26, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

3.6 years

First QC Date

April 15, 2016

Last Update Submit

April 16, 2019

Conditions

Keywords

Family PlanningLNG-IUSHealth Education

Outcome Measures

Primary Outcomes (1)

  • Change in LNG-IUS knowledge, satisfaction and continuation from baseline

    Using standardize questionnaires we will assess any significant differences in LNG-IUS knowledge, satisfaction or continuation after 6 months between control arm and intervention arm subjects.

    6 months

Secondary Outcomes (4)

  • Percent of subjects in Phase II who complete all 3 surveys on-time over 6 months compared by recruitment method and site

    6 months

  • Number of subjects reporting LNG-IUS discontinuation during the study time frame (6 months) by reason for LNG-IUS removal

    6 months

  • LNG-IUS user self-reported satisfaction with video counseling

    6 months

  • LNG-IUS user self-reported LNG-IUS healthcare utilization during study period

    baseline, 3 months, 6 months

Study Arms (2)

Control Video

SHAM COMPARATOR

Participants in this study arm will be assigned to watch a short educational video about new pap screening guidelines for women. Intervention: Cancer Screening Guidelines.

Other: Cancer Screening Guidelines

Intervention Video

ACTIVE COMPARATOR

Participants in this group will be assigned to watch a short educational video providing anticipatory counseling on their LNG-IUS' side effects and expected changes in bleeding. Intervention: Anticipatory Counseling

Other: Anticipatory Counseling

Interventions

Anticipatory Counseling provides information on expected side-effects that may change or go away over time, or stay for the duration of the treatment. Anticipatory counseling can also help patients understand when their side-effects are normal and when to seek medical attention.

Intervention Video

Anticipatory Counseling on United States Preventative Services Task Force (USPSTF) updated pap screening guidelines

Control Video

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18 and over who are deemed appropriate candidates be their healthcare providers and choose to use LNG-IUS, either Mirena or Skyla.
  • Within five days of FIRST using either Mirena or Skyla
  • Willing to answer online questions before and after watching the assigned video (intervention or control)
  • Willing to complete short online questionnaire at three and six months
  • Has working email and/or phone number
  • Able to understand verbal and written English
  • Appropriate LNG-IUS candidates whoa re being treated for other pre-existing medical disorders while using the LNG IUS may continue to take their medications as directed by their healthcare provider.

You may not qualify if:

  • Women aged less than 18 years old
  • Initiated LNG-IUS method more than five days from enrollment date.
  • Within six weeks postpartum
  • Breastfeeding
  • Using LNG-IUS for treatment other than contraception
  • Do not have access to the Web
  • Have neither working email or phone number
  • Does not understand written or verbal English
  • Inappropriate candidates for LNG IUS as deemed by healthcare provider

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of California Los Angeles Medical Center

Los Angeles, California, 90095, United States

Location

Stroger Hospital of Cook County

Chicago, Illinois, 60612, United States

Location

University of Washington Medical Centers

Seattle, Washington, 98112, United States

Location

MeSH Terms

Conditions

Uterine HemorrhageHealth Education

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Emily Godfrey, MD, MPH

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Family Medicine

Study Record Dates

First Submitted

April 15, 2016

First Posted

April 26, 2016

Study Start

March 1, 2016

Primary Completion

October 1, 2019

Study Completion

December 1, 2019

Last Updated

April 18, 2019

Record last verified: 2019-04

Locations